Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 175

1.

Immune-modulation by polyclonal IgM treatment reduces atherosclerosis in hypercholesterolemic apoE-/- mice.

Cesena FH, Dimayuga PC, Yano J, Zhao X, Kirzner J, Zhou J, Chan LF, Lio WM, Cercek B, Shah PK, Chyu KY.

Atherosclerosis. 2012 Jan;220(1):59-65. doi: 10.1016/j.atherosclerosis.2011.10.002. Epub 2011 Oct 12.

PMID:
22062590
[PubMed - indexed for MEDLINE]
Free Article
2.

Early hypercholesterolemia contributes to vasomotor dysfunction and injury associated atherogenesis that can be inhibited by nitric oxide.

Raman KG, Gandley RE, Rohland J, Zenati MS, Tzeng E.

J Vasc Surg. 2011 Mar;53(3):754-63. doi: 10.1016/j.jvs.2010.09.038. Epub 2010 Dec 15.

PMID:
21163611
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.

Zhou X, Robertson AK, Rudling M, Parini P, Hansson GK.

Circ Res. 2005 Mar 4;96(4):427-34. Epub 2005 Jan 20.

PMID:
15662027
[PubMed - indexed for MEDLINE]
Free Article
4.

Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice.

Huang K, Li SQ, Wang WJ, Liu LS, Jiang YG, Feng PN, Wang YQ, Wang SM.

Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2):397-406.

PMID:
22697071
[PubMed - indexed for MEDLINE]
5.

Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE and APOECD40L mice.

Smook ML, van Leeuwen M, Heeringa P, Damoiseaux JG, Theunissen R, Daemen MJ, Lutgens E, Tervaert JW.

Clin Exp Immunol. 2008 Nov;154(2):264-9. doi: 10.1111/j.1365-2249.2008.03746.x. Epub 2008 Sep 5.

PMID:
18778362
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells.

Dietrich T, Hucko T, Schneemann C, Neumann M, Menrad A, Willuda J, Atrott K, Stibenz D, Fleck E, Graf K, Menssen HD.

Atherosclerosis. 2012 Feb;220(2):329-36. doi: 10.1016/j.atherosclerosis.2011.09.050. Epub 2011 Oct 5.

PMID:
22062588
[PubMed - indexed for MEDLINE]
7.

Changes in immune responses to oxidized LDL epitopes during aging in hypercholesterolemic apoE(-/-) mice.

Dimayuga PC, Zhao X, Yano J, Chyu KY.

Am J Physiol Regul Integr Comp Physiol. 2006 Dec;291(6):R1644-50. Epub 2006 Jul 6.

PMID:
16825416
[PubMed - indexed for MEDLINE]
8.

A functional role for inducible costimulator (ICOS) in atherosclerosis.

Afek A, Harats D, Roth A, Keren G, George J.

Atherosclerosis. 2005 Nov;183(1):57-63. Epub 2005 Jun 6.

PMID:
15941568
[PubMed - indexed for MEDLINE]
9.

Increased gene dosage of the Ink4/Arf locus does not attenuate atherosclerosis development in hypercholesterolaemic mice.

Fuster JJ, Molina-Sánchez P, Jovaní D, Vinué Á, Serrano M, Andrés V.

Atherosclerosis. 2012 Mar;221(1):98-105. doi: 10.1016/j.atherosclerosis.2011.12.013. Epub 2011 Dec 17.

PMID:
22226369
[PubMed - indexed for MEDLINE]
10.

Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice.

Faria-Neto JR, Chyu KY, Li X, Dimayuga PC, Ferreira C, Yano J, Cercek B, Shah PK.

Atherosclerosis. 2006 Nov;189(1):83-90. Epub 2006 Jan 18.

PMID:
16386745
[PubMed - indexed for MEDLINE]
11.

Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice.

Macritchie N, Grassia G, Sabir SR, Maddaluno M, Welsh P, Sattar N, Ialenti A, Kurowska-Stolarska M, McInnes IB, Brewer JM, Garside P, Maffia P.

Arterioscler Thromb Vasc Biol. 2012 Nov;32(11):2569-79. doi: 10.1161/ATVBAHA.112.251314. Epub 2012 Aug 30.

PMID:
22936340
[PubMed - indexed for MEDLINE]
Free Article
12.

Dietary rice protein isolate attenuates atherosclerosis in apoE-deficient mice by upregulating antioxidant enzymes.

Burris RL, Xie CH, Thampi P, Wu X, Melnyk SB, Nagarajan S.

Atherosclerosis. 2010 Sep;212(1):107-15.

PMID:
20839391
[PubMed - indexed for MEDLINE]
13.

Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.

Koulis C, Chen YC, Hausding C, Ahrens I, Kyaw TS, Tay C, Allen T, Jandeleit-Dahm K, Sweet MJ, Akira S, Bobik A, Peter K, Agrotis A.

Arterioscler Thromb Vasc Biol. 2014 Mar;34(3):516-25. doi: 10.1161/ATVBAHA.113.302407. Epub 2014 Jan 16.

PMID:
24436372
[PubMed - indexed for MEDLINE]
14.

Attenuation of experimental atherosclerosis by interleukin-19.

Ellison S, Gabunia K, Kelemen SE, England RN, Scalia R, Richards JM, Orr AW, Traylor JG Jr, Rogers T, Cornwell W, Berglund LM, Goncalves I, Gomez MF, Autieri MV.

Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2316-24. doi: 10.1161/ATVBAHA.113.301521. Epub 2013 Aug 15. Erratum in: Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):e1. Orr, Wayne [corrected to Orr, A Wayne].

PMID:
23950143
[PubMed - indexed for MEDLINE]
15.

Chronic hyperbaric oxygen treatment elicits an anti-oxidant response and attenuates atherosclerosis in apoE knockout mice.

Kudchodkar BJ, Pierce A, Dory L.

Atherosclerosis. 2007 Jul;193(1):28-35. Epub 2006 Sep 14.

PMID:
16973170
[PubMed - indexed for MEDLINE]
16.

Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.

Klingenberg R, Lebens M, Hermansson A, Fredrikson GN, Strodthoff D, Rudling M, Ketelhuth DF, Gerdes N, Holmgren J, Nilsson J, Hansson GK.

Arterioscler Thromb Vasc Biol. 2010 May;30(5):946-52. doi: 10.1161/ATVBAHA.109.202671. Epub 2010 Feb 18.

PMID:
20167655
[PubMed - indexed for MEDLINE]
Free Article
17.

The pro-inflammatory effect of uraemia overrules the anti-atherogenic potential of immunization with oxidized LDL in apoE-/- mice.

Pedersen TX, Binder CJ, Fredrikson GN, Nilsson J, Bro S, Nielsen LB.

Nephrol Dial Transplant. 2010 Aug;25(8):2486-91. doi: 10.1093/ndt/gfq059. Epub 2010 Feb 17.

PMID:
20164045
[PubMed - indexed for MEDLINE]
Free Article
18.

CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis.

Packard RR, Maganto-García E, Gotsman I, Tabas I, Libby P, Lichtman AH.

Circ Res. 2008 Oct 24;103(9):965-73. doi: 10.1161/CIRCRESAHA.108.185793. Epub 2008 Oct 2.

PMID:
18832748
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe⁻(/)⁻ mice.

Kolbus D, Ramos OH, Berg KE, Persson J, Wigren M, Björkbacka H, Fredrikson GN, Nilsson J.

BMC Immunol. 2010 Dec 2;11:58. doi: 10.1186/1471-2172-11-58.

PMID:
21126329
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet.

Papadopoulos P, Bousette N, Al-Ramli W, You Z, Behm DJ, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.

Atherosclerosis. 2009 Jun;204(2):395-404. doi: 10.1016/j.atherosclerosis.2008.10.044. Epub 2008 Nov 21.

PMID:
19111831
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk